Spectrum Pharmaceuticals (SPPI) Coverage Initiated at Cantor
Cantor Fitzgerald started coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) in a research report sent to investors on Thursday, February 7th, Marketbeat reports. The firm issued an overweight rating and a $19.00 target price
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.